NIH Will Conduct Clinical Trials Of TPOXX For Monkeypox In The U.S., DRC

By Jessica Karins / August 15, 2022 at 12:34 PM
The National Institutes of Health will conduct two clinical trials of the smallpox drug TPOXX (tecovirimat) —— one in the Democratic Republic of the Congo and another in the United States — to see whether the drug can be safely and effectively used to treat monkeypox, including in the outpatient setting, the White House said in a fact sheet published Thursday (Aug. 11). The announcement follows the White House’s publication last month of its broader $140 million monkeypox research plan...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.